(PharmaNewsWire.Com, September 16, 2017 ) The Global Cell Based Assay Market was worth USD 10.5 billion in 2016 and estimated to be growing at a CAGR of 11.2%, to reach USD 17.85 billion by 2021. Cell based assays are majorly used by biotechnology companies, academic research institutes, contract research organizations government institutions, pharmaceutical companies and others.
Cell based assay is a technique of examining living cell on the basis of diverse parameters. Cell based Market assays are used to determine virtually functions of cellular or biochemical processes. In cell based assays, functional cells are used as analytical tools in research for novel drugs. Cell based assays ease research in the area of immunology, stem cells, cancer and others.
Growing research activities in drug discovery, technological development, increase in demand for biological drugs, government spending, increasing need for toxicity screening in drugs are likely to drive the market for cell based assays. Additionally, important advantages of cell based assay, innovation in technologically advanced products and need to decrease costs associated with drug discovery are anticipated to drive the market for cell based assays. However, short of skilled professionals, severe intellectual property rights and high cost of instruments are some of the factors restraining the growth for global cell based assays market.
The global cell based assay market is segmented on the basis of type of product into Cell Lines, Assay Ready Kits, Cell Culture Kits, Reagents & Consumables and Ligands & Inhibitors. Cell Lines segment is further divided into Primary Cell Lines, Stem Cell Lines and Immortalized Cell Lines. On the basis of technology, market is segregated into Automated Handling, Flow Cytometry, Label-Free Detection, High Content Screening and High Throughput Screening. Based on application market is bifurcated among Drug Discovery and ADME Research. By End User type, segmentation is among Academia, Biotechnology, Pharmaceuticals and CRO.
Based on geography the market is analysed under various regions namely, North America, Latin America, Europe, Asia-Pacific and Middle-East & Africa. North America, followed by Europe, has the biggest market for cell based assays due to rising drug related research & development activities, increase in adoption of cell based assay platforms and huge number of pharmaceutical and biotechnology companies in this region. Asia is expected to show high growth rate in the cell based assays market in next few years.
The top leaders in cell-based assays market include Thermo Fisher Scientific Inc., Becton, Dickinson and Company, Merck & Co. Inc., Cell Signalling Technology Inc., PerkinElmer Inc., Danaher Corporation, General Electric Company, Cisbio Bioassays, DiscoveRx, Ametek Inc., Bio-Rad Laboratories, Roche Diagnostics, GE Healthcare and Promega Corporation.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
